A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach
Peter S. Pang, John R. Teerlink(San Francisco VA Medical Center), John G.F. Cleland(University of Glasgow), John Kirk(Université Paris-Saclay), Gerasimos Filippatos(University General Hospital Attikon), George Sopko(National Heart Lung and Blood Institute), W. Frank Peacock(Ben Taub Hospital), Alan B. Storrow(Vanderbilt University Medical Center), Sean P. Collins(Georgetown University), Edmond Roland(Agence Nationale de Sécurité du Médicament et des Produits de Santé), Amer Z. Aldeen(Northwestern University), Gregg C. Fonarow(University of California, Los Angeles), Alexandre Mebazaa(Délégation Paris 5), Miguel Tavares(Hospital de Santo António), Michel Komajda(Inserm), Alan Maisel(UC San Diego Health System), Barry M. Massie(University of California, San Francisco), Christopher J. Lindsell(Vanderbilt University Medical Center), Mihai Gheorghiade(Northwestern University)
Cited by 137
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction
|Circulation|2010|4.8k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
|European Heart Journal|2011|3.5k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
|European Journal of Heart Failure|2008|3.5k